Literature DB >> 11676530

Recent advances in the molecular biology of hepatitis C virus.

S Rosenberg1.   

Abstract

The Hepatitis C virus is a positive-stranded RNA virus which is the causal agent for a chronic liver infection afflicting more than 170,000,000 people world-wide. The HCV genome is approximately 9.6 kb in length and the proteome encoded is a polyprotein of a little more than 3000 amino acid residues. This polyprotein is processed by a combination of host and viral proteases into structural and non-structural proteins. The functions of most of these proteins have been established by analogy to other viruses and by sequence homology to known proteins, as well as subsequent biochemical analysis. Two of the non-structural proteins, NS4b and NS5a, are still of unknown function. The development of antivirals for this infectious agent has been hampered by the lack of robust and economical cell culture and animal infection systems. Recent progress in the molecular virology of HCV has come about due to the definition of molecular clones, which are infectious in the chimpanzee, the development of a subgenomic replicon system in Huh7 cells, and the description of a transgenic mouse model for HCV infection. Recent progress in the structural biology of the virus has led to the determination of high resolution three-dimensional structures of a number of the key virally encoded enzymes, including the NS3 protease, NS3 helicase, and NS5b RNA-dependent RNA polymerase. In some cases these structures have been determined in complex with substrates, co-factors (NS4a), and inhibitors. Finally, a variety of techniques have been used to define host factors, which may be required for HCV replication, although this work is just beginning. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676530     DOI: 10.1006/jmbi.2001.5055

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  41 in total

1.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

2.  Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.

Authors:  E Rodríguez-Iñigo; J Bartolomé; N Ortiz-Movilla; C Platero; J M López-Alcorocho; M Pardo; I Castillo; V Carreño
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells.

Authors:  Pruksa Nawtaisong; Mark E Fraser; James R Carter; Malcolm J Fraser
Journal:  Virology       Date:  2015-04-07       Impact factor: 3.616

4.  Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.

Authors:  Rongtuan Lin; Judith Lacoste; Peyman Nakhaei; Qiang Sun; Long Yang; Suzanne Paz; Peter Wilkinson; Ilkka Julkunen; Damien Vitour; Eliane Meurs; John Hiscott
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  The induction of type I interferon production in hepatitis C-infected patients.

Authors:  Lawrence M Pfeffer; Margaret A Madey; Caroline A Riely; Jaquelyn F Fleckenstein
Journal:  J Interferon Cytokine Res       Date:  2009-05       Impact factor: 2.607

6.  Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C.

Authors:  Javier Bartolomé; Juan Manuel López-Alcorocho; Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Antonio Quiroga; Ricardo Palacios; Vicente Carreño
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

7.  Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif.

Authors:  Björn Schwer; Shaotang Ren; Thomas Pietschmann; Jürgen Kartenbeck; Katrin Kaehlcke; Ralf Bartenschlager; T S Benedict Yen; Melanie Ott
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Morphine enhances hepatitis C virus (HCV) replicon expression.

Authors:  Yuan Li; Ting Zhang; Steven D Douglas; Jian-Ping Lai; Wei-Dong Xiao; David E Pleasure; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.

Authors:  Fang Chen; Yilan Hu; Dongqing Li; Haidan Chen; Xiao-Lian Zhang
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

10.  Positioning of subdomain IIId and apical loop of domain II of the hepatitis C IRES on the human 40S ribosome.

Authors:  Elena Babaylova; Dmitri Graifer; Alexey Malygin; Joachim Stahl; Ivan Shatsky; Galina Karpova
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.